Bafna Pharmaceuticals Ltd

BSE :532989 NSE :BAFNAPH Sector : Pharmac..
71.95
Change: -0.55(-0.76%)
52 week Low
69.00
52 week High
113.00
Day low
69
Day high
75.99
Prev Close
72.50
Open
70.20
6M return
-12.36%
1Y return
-21.19%
MCap(Rs. in Cr.)
171.51
Total Volume
821
Face Value : 10
Listed Since 27 Jun 2008
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Bafna Pharma.
71.95
Change: -0.55 (-0.76%)
1 Year return
-21.19%
Risk (Std Dev)
0.11%
PE Ratio
34.79
MCap( in Cr.)
171.51
Kopran
177.43
Change: 2.90 (1.66%)
1 Year return
-34.83%
Risk (Std Dev)
0.12%
PE Ratio
17.77439
MCap( in Cr.)
842.73
Megasoft
62.31
Change: 2.96 (4.99%)
1 Year return
-25.33%
Risk (Std Dev)
0.20%
PE Ratio
NM
MCap( in Cr.)
437.83
SMS Lifesciences
1,187.45
Change: 1187.45 (0.00%)
1 Year return
0.00%
Risk (Std Dev)
-
PE Ratio
15.37856
MCap( in Cr.)
377.90
Krebs Biochem
85.95
Change: 0.96 (1.13%)
1 Year return
15.52%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
183.24
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Bafna Pharmaceuticals reports standalone net profit of Rs 0.95 crore in the December 2024 quarter

Net profit of Bafna Pharmaceuticals reported to Rs 0.95 crore in the quarter ended December 2024 as against net loss of Rs 2.94 crore during the previ....

06 Feb 2025 18:13

Bafna Pharmaceuticals announces board meeting date

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live Ne....

28 Jan 2025 17:34

Bafna Pharmaceuticals standalone net profit rises 5.65% in the September 2024 quarter

Net profit of Bafna Pharmaceuticals rose 5.65% to Rs 2.62 crore in the quarter ended September 2024 as against Rs 2.48 crore during the previous quart....

11 Nov 2024 18:03

Bafna Pharmaceuticals to discuss results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live Ne....

04 Nov 2024 18:39

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital....

05 Sep 2024 10:29

Bafna Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the June 2024 quarter

Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as against net profit of Rs 6.35 crore during the previous ....

13 Aug 2024 16:36

View More
Subscribe for our
newsletter
Open Account Now